Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2008-09-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0800041105PMID 18768809PMCID PMC2533226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

  2007cited by this paper
• Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice

  2007cited by this paper
• Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer.

  2007cited by this paper
• TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

  2006cited by this paper
• TOR signaling in growth and metabolism.

  2006cited by this paper
• mTOR, translation initiation and cancer

  2006cited by this paper
• mTOR and cancer therapy

  2006cited by this paper
• Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation

  2006cited by this paper
• Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells

  2004cited by this paper
• Roles of Phosphatidylinositol 3′-Kinase and Mammalian Target of Rapamycin/p70 Ribosomal Protein S6 Kinase in K-Ras-Mediated Transformation of Intestinal Epithelial Cells

  2004cited by this paper
• The tor pathway: a target for cancer therapy

  2004cited by this paper
• Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.

  2004cited by this paper
• mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

  2004cited by this paper
• mTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms

  2004cited by this paper
• Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

  2004cited by this paper
• Glutamine is a key regulator for amino acid-controlled cell growth through the mTOR signaling pathway in rat intestinal epithelial cells.

  2004cited by this paper
• Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin.

  2003cited by this paper
• TSC2 mediates cellular energy response to control cell growth and survival.

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Δ716 Cdx2+/− compound mutant mice

  2003cited by this paper
• The -Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells

  2002cited by this paper
• The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

  2002cited by this paper
• Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

  2002cited by this paper
• APC, Signal transduction and genetic instability in colorectal cancer

  2001cited by this paper
• Mouse by Rofecoxib , a Specific Cyclooxygenase-2 Inhibitor 716 ∆ Apc Chemoprevention of Intestinal Polyposis in the Updated Version

  2001cited by this paper
• Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice

  2001cited by this paper
• An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice

  2001cited by this paper
• Cyclin D1 Expression Mediated by Phosphatidylinositol 3-Kinase through mTOR-p70S6K-Independent Signaling in Growth Factor-Stimulated NIH 3T3 Fibroblasts

  1999cited by this paper
• Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene

  1999cited by this paper
• Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

  1999cited by this paper
• p70 S6 Kinase-mediated Protein Synthesis Is a Critical Step for Vascular Endothelial Cell Proliferation*

  1999cited by this paper
• Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

  1997cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.

  1995cited by this paper

• BCL-2 family inhibition enhances MTORC1/2 inhibition in PIK3CA mutant colorectal cancer.

  2025cites this paper
• From Genes To Gut: Evolving Strategies in Pediatric Polyposis Syndromes

  2025cites this paper
• A bibliometric and visual analysis of the impact of senescence on tumor immunotherapy

  2025cites this paper
• Enteroendocrine cell differentiation: implications for human disease.

  2025cites this paper
• Wnt Signaling Pathway in Tumor Biology

  2024cites this paper
• Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer

  2024cites this paper
• A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy.

  2024cites this paper
• Interplay between WNT/PI3K-mTOR axis and the microbiota in APC-driven colorectal carcinogenesis: data from a pilot study and possible implications for CRC prevention

  2024cites this paper
• Successful treatment of juvenile polyposis of infancy with sirolimus: a case report

  2024cites this paper
• Wnt3a-induced LRP6 phosphorylation enhances osteoblast differentiation to alleviate osteoporosis through activation of mTORC1/β-catenin signaling.

  2024cites this paper
• The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics.

  2023cites this paper
• Subependymal Giant Cell Astrocytoma Non-Associated With Tuberous Sclerosis Complex and Expression of OCT-4 and INI-1: A Case Report

  2023cites this paper
• Cancer prevention with rapamycin

  2023cites this paper
• The effects of arginine and branched-chain amino acid supplementation to reduced-protein diet on intestinal health, cecal short-chain fatty acid profiles, and immune response in broiler chickens challenged with Eimeria spp.

  2023cites this paper
• mTOR inhibition suppresses Myc-driven polyposis by inducing immunogenic cell death

  2023cites this paper
• When You Come to a Fork in the Road, Take It: Wnt Signaling Activates Multiple Pathways through the APC/Axin/GSK-3 Complex

  2023cites this paper
• Chemoprevention in Inherited Colorectal Cancer Syndromes

  2023cites this paper
• A Review of the Clinical Presentation, Outcomes, and Treatments of Patients Having Desmoid Tumors

  2023cites this paper
• Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action

  2023cites this paper
• A pilot study evaluating the use of sirolimus in children and young adults with desmoid‐type fibromatosis

  2023cites this paper
• Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review

  2023cites this paper
• Efficacy of Wholistic Turmeric Supplement on Adenomatous Polyps in Patients with Familial Adenomatous Polyposis—A Randomized, Double-Blinded, Placebo-Controlled Study

  2022cites this paper
• Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.

  2022cites this paper
• Adenomatous polyposis coli in cancer and therapeutic implications

  2021cites this paper
• Role of adenomatous polyposis coli in proliferation and differentiation of colon epithelial cells in organoid culture

  2021cites this paper
• Roles of Src family kinase, Ras, and mTOR signaling in intestinal epithelial homeostasis and tumorigenesis

  2020cites this paper
• Effect of rapamycin on aging and age-related diseases—past and future

  2020cites this paper
• Prognostic role of aberrant mTOR activation in patients with stage II and III colorectal cancer.

  2020cites this paper
• Sex-dependent lifespan extension of Apc Min/+ FAP mice by chronic mTOR inhibition.

  2020cites this paper
• Regulation of colonic epithelial cell homeostasis by mTORC1

  2020cites this paper
• Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?

  2020cites this paper
• Targeting Protein Synthesis in Colorectal Cancer

  2020cites this paper
• Synthetic lethality between MyD88 loss and mutations in Wnt/β-catenin pathway in intestinal tumor epithelial cells

  2020cites this paper
• Metabolic and immunologic control of intestinal cell function by mTOR.

  2020cites this paper
• Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model.

  2020cites this paper
• mTOR signaling in mouse models of accelerated aging.

  2019cites this paper
• CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells

  2019cites this paper
• Regulation of Small Intestinal Epithelial Homeostasis by Tsc2-mTORC1 Signaling.

  2019cites this paper
• Title Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in Apc [ Δ 716 ] mice involves stromal

  2019cites this paper
• Role of mTORC1 in intestinal epithelial repair and tumorigenesis

  2019cites this paper
• Diet, Microbiota, and Colorectal Cancer

  2019cites this paper
• Revisiting mTOR inhibitors as anticancer agents.

  2019cites this paper
• Sustainable Positive Response to Sirolimus in Juvenile Polyposis of Infancy.

  2018cites this paper
• Inositol-6 phosphate inhibits the mTOR pathway and induces autophagy-mediated death in HT-29 colon cancer cells

  2018cites this paper
• Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.

  2018cites this paper
• Cysteine‐rich protein 61 regulates adipocyte differentiation from mesenchymal stem cells through mammalian target of rapamycin complex 1 and canonical Wnt signaling

  2018cites this paper
• mTORC1 signaling suppresses Wnt/β-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level

  2018cites this paper
• A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates

  2018cites this paper
• Two Cases of Sinonasal Non-Intestinal-Type Adenocarcinoma with Squamoid Morules Expressing Nuclear β-Catenin and CDX2: A Curious Morphologic Finding Supported by Molecular Analysis

  2018cites this paper
• Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management

  2017cites this paper
• CDX2 Stimulates the Proliferation of Porcine Intestinal Epithelial Cells by Activating the mTORC1 and Wnt/β-Catenin Signaling Pathways

  2017cites this paper
• Stem Cells, Cancer, and MUSASHI in Blood and Guts.

  2017cites this paper
• Invitro Evaluation of Torin2 and 2, 6-Dihydroxyacetophenone in Colorectal Cancer Therapy

  2017cites this paper
• Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma

  2017cites this paper
• Comprehensive Review on Colorectal Cancer and Transplant

  2017cites this paper
• HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis.

  2016cites this paper
• Intestinal Epithelial-Specific mTORC1 Activation Enhances Intestinal Adaptation After Small Bowel Resection

  2016cites this paper
• CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, β-Catenin, and hTERT Activities

  2016cites this paper
• Adaptations to chronic rapamycin in mice

  2016cites this paper
• Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations

  2016cites this paper
• mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice

  2016cites this paper
• Desmoid-Type Fibromatosis: Evolving Treatment Standards.

  2016cites this paper
• Lentivirus‐mediated somatic recombination and development of a novel mouse model for sporadic colorectal cancer

  2016influential citation
• Wnt Signaling in Normal and Malignant Stem Cells

  2016cites this paper
• Rapamycin Reverses Metabolic Deficits in Lamin A/C-Deficient Mice.

  2016cites this paper
• Familial Adenomatous Polyposis; Succesful Use of Sirolimus

  2016cites this paper
• Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites

  2016cites this paper
• Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes.

  2016cites this paper
• Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APCMin/+ mice

  2016cites this paper
• Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth

  2015cites this paper
• Optimal therapy for desmoid tumors: current options and challenges for the future

  2015cites this paper
• Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses.

  2015cites this paper
• Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles.

  2015cites this paper
• The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins.

  2015cites this paper
• Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in ApcΔ716 mice involves stromal COX-2

  2015cites this paper
• Transformation of the intestinal epithelium by the MSI2 RNA binding protein

  2015cites this paper
• Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.

  2015cites this paper
• How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.

  2015cites this paper
• Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models

  2015cites this paper
• New Insights into the Mechanism of Action of Aspirin in the Prevention of Colorectal Neoplasia.

  2015cites this paper
• The role of the PI3K pathway in colorectal cancer.

  2015cites this paper
• mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction upon 4E-BP1 dephosphorylation

  2015cites this paper
• Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract

  2015cites this paper
• Overview of Genetically Engineered Mouse Models of Colorectal Carcinoma to Enable Translational Biology and Drug Development

  2014cites this paper
• Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt–β-catenin–mediated intestinal tumor growth and regeneration

  2014cites this paper
• Étude du rôle de l’autophagie dans la cancérogenèse intestinale

  2014cites this paper
• Molecular Pathways: IL11 as a Tumor-Promoting Cytokine—Translational Implications for Cancers

  2014cites this paper
• Rapamycin Inhibition of Polyposis and Progression to Dysplasia in a Mouse Model

  2014cites this paper
• Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer.

  2014cites this paper
• Salinomycin Suppresses LRP6 Expression and Inhibits Both Wnt/β‐catenin and mTORC1 Signaling in Breast and Prostate Cancer Cells

  2014influential citation
• mTORC1 mediated translational elongation limits intestinal tumour initiation and growth

  2014cites this paper
• PGE2-induced colon cancer growth is mediated by mTORC1.

  2014cites this paper
• Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.

  2014cites this paper
• Hypothesis: cell signalling influences age-related risk of colorectal cancer

  2014influential citation
• Loss of α-catenin elicits a cholestatic response and impairs liver regeneration

  2014cites this paper
• Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy—A Potential Strategy for Improved Survival

  2014cites this paper
• Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish

  2013influential citation
• Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma

  2013cites this paper
• Mechanistic target of rapamycin in common carp: cDNA cloning, characterization, and tissue expression.

  2013cites this paper
• Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR

  2013cites this paper